Taipei, Taiwan

I-Huang Lu

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 10.0

ph-index = 1


Location History:

  • Zhudong Township, TW (2017)
  • Taipei, TW (2017 - 2020)
  • Hsinchu, TW (2022)

Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by I-Huang Lu in Autoimmune Disease Treatment

Introduction

I-Huang Lu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the treatment of autoimmune neurological diseases and neurodegenerative diseases. With a total of 4 patents, his work is paving the way for new therapeutic approaches.

Latest Patents

I-Huang Lu's latest patents include a method for treating autoimmune neurological diseases and neurodegenerative diseases. This method involves administering an effective amount of specific compounds to subjects in need. Additionally, he has developed a pharmaceutical composition aimed at treating or alleviating autoimmune diseases and complications, including nephritis. This composition utilizes extracts from plants as effective ingredients for various autoimmune conditions.

Career Highlights

I-Huang Lu is affiliated with the Industrial Technology Research Institute, where he conducts research and development in innovative pharmaceutical solutions. His work has garnered attention for its potential impact on treating complex autoimmune disorders.

Collaborations

I-Huang Lu collaborates with notable colleagues, including Shu-Fang Wen and Zong-Keng Kuo, to advance research in his field. Their combined expertise contributes to the development of effective treatments for challenging medical conditions.

Conclusion

I-Huang Lu's innovative work in the treatment of autoimmune diseases showcases his dedication to improving patient outcomes through research and development. His contributions are vital in the ongoing quest for effective therapies in this critical area of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…